These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 24029664)
21. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. Chen JJ; Yao PL; Yuan A; Hong TM; Shun CT; Kuo ML; Lee YC; Yang PC Clin Cancer Res; 2003 Feb; 9(2):729-37. PubMed ID: 12576442 [TBL] [Abstract][Full Text] [Related]
22. Promotion of macrophage-stimulated autoreactive T cell proliferation by interleukin-10: counteraction of macrophage suppressor activity during tumor growth. Alleva DG; Elgert KD Immunobiology; 1995 Feb; 192(3-4):155-71. PubMed ID: 7782092 [TBL] [Abstract][Full Text] [Related]
23. Crosstalk between M2 macrophages and glioma stem cells. Nusblat LM; Carroll MJ; Roth CM Cell Oncol (Dordr); 2017 Oct; 40(5):471-482. PubMed ID: 28643230 [TBL] [Abstract][Full Text] [Related]
24. Rat resident testicular macrophages have an alternatively activated phenotype and constitutively produce interleukin-10 in vitro. Winnall WR; Muir JA; Hedger MP J Leukoc Biol; 2011 Jul; 90(1):133-43. PubMed ID: 21498587 [TBL] [Abstract][Full Text] [Related]
25. Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection. Tsung K; Dolan JP; Tsung YL; Norton JA Cancer Res; 2002 Sep; 62(17):5069-75. PubMed ID: 12208763 [TBL] [Abstract][Full Text] [Related]
26. Decreased IL-10 expression in stefin B-deficient macrophages is regulated by the MAP kinase and STAT-3 signaling pathways. Maher K; Završnik J; Jerič-Kokelj B; Vasiljeva O; Turk B; Kopitar-Jerala N FEBS Lett; 2014 Mar; 588(5):720-6. PubMed ID: 24462687 [TBL] [Abstract][Full Text] [Related]
27. Mouse bone marrow-derived mesenchymal stem cells induce macrophage M2 polarization through the nuclear factor-κB and signal transducer and activator of transcription 3 pathways. Gao S; Mao F; Zhang B; Zhang L; Zhang X; Wang M; Yan Y; Yang T; Zhang J; Zhu W; Qian H; Xu W Exp Biol Med (Maywood); 2014 Mar; 239(3):366-75. PubMed ID: 24500984 [TBL] [Abstract][Full Text] [Related]
28. CD5 promotes IL-10 production in chronic lymphocytic leukemia B cells through STAT3 and NFAT2 activation. Garaud S; Morva A; Lemoine S; Hillion S; Bordron A; Pers JO; Berthou C; Mageed RA; Renaudineau Y; Youinou P J Immunol; 2011 Apr; 186(8):4835-44. PubMed ID: 21398617 [TBL] [Abstract][Full Text] [Related]
29. Expression of Th17-related genes in PHA/IL-2-activated human T cells by Fas signaling via caspase-1- and Stat3-dependent pathway. Su CC; Lin HC; Lin YP; Shan YS; Yang BC Cell Immunol; 2013 Feb; 281(2):101-10. PubMed ID: 23590971 [TBL] [Abstract][Full Text] [Related]
30. M2 macrophage/microglial cells induce activation of Stat3 in primary central nervous system lymphoma. Komohara Y; Horlad H; Ohnishi K; Ohta K; Makino K; Hondo H; Yamanaka R; Kajiwara K; Saito T; Kuratsu J; Takeya M J Clin Exp Hematop; 2011; 51(2):93-9. PubMed ID: 22104307 [TBL] [Abstract][Full Text] [Related]
31. Expression of chemokine-like receptor 1 (CMKLR1) on J744A.1 macrophages co-cultured with fibroblast and/or tumor cells: modeling the influence of microenvironment. Rama D; Esendagli G; Guc D Cell Immunol; 2011; 271(1):134-40. PubMed ID: 21752353 [TBL] [Abstract][Full Text] [Related]
32. Impact of EGFR immunoexpression on STAT3 activation and association with proinflammatory/regulatory cytokine pattern in laryngeal squamous cell carcinoma. Starska K; Brys M; Forma E; Glowacka E; Lewy-Trenda I; Stasikowska O; Krajewska WM; Lukomski M Oncol Rep; 2009 Feb; 21(2):539-48. PubMed ID: 19148533 [TBL] [Abstract][Full Text] [Related]
33. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes. Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103 [TBL] [Abstract][Full Text] [Related]
34. Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis. Sinha P; Clements VK; Ostrand-Rosenberg S Cancer Res; 2005 Dec; 65(24):11743-51. PubMed ID: 16357187 [TBL] [Abstract][Full Text] [Related]
35. Induced expression of B7-H4 on the surface of lung cancer cell by the tumor-associated macrophages: a potential mechanism of immune escape. Chen C; Qu QX; Shen Y; Mu CY; Zhu YB; Zhang XG; Huang JA Cancer Lett; 2012 Apr; 317(1):99-105. PubMed ID: 22108530 [TBL] [Abstract][Full Text] [Related]
36. BMP-6 in renal cell carcinoma promotes tumor proliferation through IL-10-dependent M2 polarization of tumor-associated macrophages. Lee JH; Lee GT; Woo SH; Ha YS; Kwon SJ; Kim WJ; Kim IY Cancer Res; 2013 Jun; 73(12):3604-14. PubMed ID: 23633487 [TBL] [Abstract][Full Text] [Related]
37. Both miR-17-5p and miR-20a alleviate suppressive potential of myeloid-derived suppressor cells by modulating STAT3 expression. Zhang M; Liu Q; Mi S; Liang X; Zhang Z; Su X; Liu J; Chen Y; Wang M; Zhang Y; Guo F; Zhang Z; Yang R J Immunol; 2011 Apr; 186(8):4716-24. PubMed ID: 21383238 [TBL] [Abstract][Full Text] [Related]
39. Use of carbosilane dendrimer to switch macrophage polarization for the acquisition of antitumor functions. Perisé-Barrios AJ; Gómez R; Corbí AL; de la Mata J; Domínguez-Soto A; Muñoz-Fernandez MA Nanoscale; 2015 Mar; 7(9):3857-66. PubMed ID: 25254497 [TBL] [Abstract][Full Text] [Related]
40. Interleukin 6 induces M2 macrophage differentiation by STAT3 activation that correlates with gastric cancer progression. Fu XL; Duan W; Su CY; Mao FY; Lv YP; Teng YS; Yu PW; Zhuang Y; Zhao YL Cancer Immunol Immunother; 2017 Dec; 66(12):1597-1608. PubMed ID: 28828629 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]